Table 2 Espirometric and BMI percentile data
From: Burkholderia cepacia complex: clinical course in cystic fibrosis patients
TIME 1 | TIME 2 | TIME 3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Parameters | Groups | Mean values | Standard deviation | P-value | Mean values | Standard deviation | P-value | Mean values | Standard deviation | P-value |
FEV1 % | I | 78.9 | 27.0 | 0.267 | 82.9 | 27.9 | 0.176 | 86.6 | 22.3 | 0.004 |
II | 70.6 | 17.2 | 66.4 | 22.4 | 52.3 | 20.1 | ||||
III | 81.5 | 22.2 | 72.6 | 22.3 | 67.0 | 18.8 | ||||
Total | 78.2 | 21.8 | 73.1 | 23.7 | 66.7 | 22.5 | ||||
FVC % | I | 85.5 | 24.2 | 88.9 | 23.4 | 93.6 | 18.7 | 0.032 | ||
II | 86.5 | 18.3 | 0.911 | 80.8 | 18.7 | 0.426 | 67.8 | 21.2 | ||
III | 89.3 | 19.2 | 82.0 | 19.4 | 78.0 | 16.7 | ||||
Total | 87.9 | 19.4 | 83.1 | 19.9 | 78.1 | 19.9 | ||||
BMI percentile | I | 41.4 | 25.4 | 43.5 | 26.9 | 45.4 | 20.8 | 0.035 | ||
II | 17.8 | 19.5 | 0.002 | 22.3 | 20.5 | 0.082 | 21.1 | 15.0 | ||
III | 53.9 | 30.3 | 45.7 | 29.2 | 45.6 | 28.4 | ||||
Total | 42.2 | 30.6 | 39.8 | 28.1 | 39.8 | 26.1 | ||||